Valeant Shares Side on Report Ex CEO, Ex CFO Focus of DOJ Criminal Probe
![Valeant](https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2018/02/931/506/rtx2g72e-2.jpg?ve=1&tl=1)
Shares of Valeant Pharmaceuticals (NYSE:VRX) tumbled as much as 6% in late trading on Monday after Bloomberg News reported the company's former CEO and CFO are the subjects of a criminal investigation by the Department of Justice for accounting fraud.
This is a breaking-news story, please check back for updates.